Showing results (251-260 of 432) with videos related to

Sort By:
Pageof 44
European Journal of Haematology|January 17, 2013
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie CellulaireSophie Park, Myriam Labopin, Ibrahim Yakoub-Agha, et al.
Kidney International Reports|December 18, 2023
Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe DiseaseMarie-Camille Lafargue, Mickaël Bobot, Helmut G Rennke, et al.
Leukemia|August 17, 2023
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patientsEkaterina Jahn, Maral Saadati, Pierre Fenaux, et al.
International Journal of Molecular Sciences|December 29, 2019
Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid LeukemiaThomas Cluzeau, Nathan Furstoss, Coline Savy, et al.
Blood|November 3, 2009
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetHartmut Döhner, Elihu H Estey, Sergio Amadori, et al.
Leukemia & Lymphoma|November 21, 2018
Gastrointestinal Behcet's-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature reviewNadege Wesner, Louis Drevon, Alexis Guedon, et al.
Leukemia Research|March 15, 2011
Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 casesThorsten Braun, Stéphane de Botton, Anne-Laure Taksin, et al.
The Lancet. Haematology|December 8, 2023
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trialAmer M Zeidan, Kiyoshi Ando, Odile Rauzy, et al.
Blood|September 20, 2002
Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trialHervé Dombret, Jean Gabert, Jean-Michel Boiron, et al.
Journal of Hematology & Oncology|June 28, 2017
Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q)Pierre Fenaux, Aristoteles Giagounidis, Dominik Selleslag, et al.
Pageof 44